Asthma prevalence and influenza and COVID-19 vaccination coverage among children aged ≤17 years with asthma

OBJECTIVE: Children with asthma are at increased risk for complications from respiratory infectious diseases. This study assessed asthma prevalence and influenza and COVID-19 vaccination coverage among children with asthma. METHODS: Data from the 2024 National Health Interview Survey (NHIS) were analyzed to assess asthma prevalence and influenza and COVID-19 vaccination coverage by asthma status among children. RESULTS: Current asthma prevalence was 6.5% among children aged ≤17 years. Prevalence was higher among children aged 5-12 years (8.2%) and 13-17 years (7.8%) compared with those aged <5 years (2.2%). Influenza and COVID-19 vaccination coverage among children with current asthma were 54.1% and 50.9%, respectively. Asthma prevalence and vaccination coverage varied by demographic and access-to-care characteristics. CONCLUSION: Asthma prevalence was higher among older children, males, and non-Hispanic Black children. Influenza and COVID-19 vaccination coverage among children with asthma remained low. Tailored strategies are needed to reduce the asthma burden and improve vaccination coverage in populations with lower uptake.